Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Actavalon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11143
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Actavalon Inc (Actavalon) is an oncology-focused company, which develops small molecule medicines targeting two basic cancer pathways, namely, the p53 tumor suppressor pathway and the aryl hydrocarbon receptor (AhR) pathway. It is developing small molecules that can stabilize the mutant p53 modulators, which restore tumor suppression activity and block gain-of-function by oncogenes in human cancer cells; and selective aryl hydrocarbon receptor modulating agonists (SAhRM) that inhibit estrogen receptor that affects the growth of ER-negative and triple negative breast cancers. The company currently functions out of the JLABS incubator on the Johnson & Johnson Innovation Labs campus in San Diego. Actavalon is headquartered in Corona del Mar, California, the US.

Actavalon Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Actavalon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Actavalon Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Actavalon to Raise USD0.3 Million in Venture Financing 10
Actavalon Raises Funds through Venture Financing 11
Actavalon Raises USD0.5 Million in Venture Financing 12
Actavalon Inc – Key Competitors 13
Actavalon Inc – Key Employees 14
Actavalon Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Actavalon Inc, Pharmaceuticals & Healthcare, Key Facts 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Actavalon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Actavalon to Raise USD0.3 Million in Venture Financing 10
Actavalon Raises Funds through Venture Financing 11
Actavalon Raises USD0.5 Million in Venture Financing 12
Actavalon Inc, Key Competitors 13
Actavalon Inc, Key Employees 14

List of Figures
Actavalon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Actavalon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Actavalon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Actavalon Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Harbin Bank Co Ltd:企業の戦略・SWOT・財務分析
    Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Harbin Bank Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Precision Drilling Corp (PD):石油・ガス:M&Aディール及び事業提携情報
    Summary Precision Drilling Corp (Precision) is a provider of onshore drilling and production services to exploration and production companies in the oil and natural gas industry. It offers contract drilling, well servicing and other support services to oil and natural gas exploration and production …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • Television Francaise 1 SA (TFI):企業の財務・戦略的SWOT分析
    Television Francaise 1 SA (TFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務情報
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ceragon Networks Ltd (CRNT):企業の財務・戦略的SWOT分析
    Ceragon Networks Ltd (CRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • UGE International Ltd (UGE):企業の財務・戦略的SWOT分析
    Summary UGE International Ltd (UGE), formerly Way Ventures Inc, is a renewable energy company that operates through wind, solar, solar-wind technologies. The company offers products such as electronics and accessories, wind turbines, solar panels, energy storage systems, mounting system, electronics …
  • Novo Nordisk AS (NOVO B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sareum Holdings Plc (SAR):企業の財務・戦略的SWOT分析
    Sareum Holdings Plc (SAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報
    Summary Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, hig …
  • Transgene SA (TNG):製薬・医療:M&Aディール及び事業提携情報
    Summary Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that offers discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company offers products such as therapeutic vaccines and oncolytic viruses. It develops targe …
  • BioStar Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Altin Yunus Cesme Turistik Tesisler A.S.
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ziehm Imaging GmbH-医療機器分野:企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …
  • Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …
  • Bank AlJazira:企業の戦略・SWOT・財務情報
    Bank AlJazira - Strategy, SWOT and Corporate Finance Report Summary Bank AlJazira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Big Lots, Inc.:企業の戦略・SWOT・財務情報
    Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report Summary Big Lots, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary The Jackson Laboratory (JAX) is a biomedical research center that offers clinical genomic solutions. The center provides breeding and rederivation services. It offers cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservatio …
  • Paoli Calmettes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Paoli Calmettes Institute (IPC) is a cancer treatment institute. The institute provides medical activities such as consultations, imaging examinations, chemotherapy preparations, radiotherapy sessions, surgical stays, endoscopies, and bone marrow and stem cell transplants. Its areas of disti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆